|
|
Exchange: |
American Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
41,630,000 |
Market
Cap: |
26.95(M) |
Last
Volume: |
204,752 |
Avg
Vol: |
427,496 |
52
Week Range: |
$0.6474 - $0.6474 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Lannett primarily develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. Co.'s primary products include: Amphetamine IR Tablets, which are used to treat Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy; Amphetamine ER Capsules, which are indicated for use to treat ADHD; Dicyclomine Tablets, which are indication for the treatment of functional bowel disorder and irritable bowel syndrome; Fluphenazine Tablets, which are used for the management of manifestations of psychotic disorders; and Levothyroxine Capsules, which are soft gel capsules used to treat patients with hypothyroidism and other conditions.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
216,159 |
Total Buy Value |
$0 |
$0 |
$0 |
$108,668 |
Total People Bought |
0 |
0 |
0 |
4 |
Total Buy Transactions |
0 |
0 |
0 |
5 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Crew Timothy C |
Chief Executive Officer |
|
2020-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
204,016 |
396,232 |
|
- |
|
Cavanaugh Maureen |
Senior Vice President and CCOO |
|
2020-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
59,573 |
118,120 |
|
- |
|
Kozlowski John |
VP of Finance & CFO |
|
2020-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
52,364 |
100,025 |
|
- |
|
Abt John |
Chief Quality and Operations |
|
2020-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
41,328 |
87,015 |
|
- |
|
Ehlinger Robert |
VP and CIO |
|
2020-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
22,422 |
70,191 |
|
- |
|
Israel Samuel H |
Chief Legal Officer |
|
2020-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
56,036 |
120,888 |
|
- |
|
Ehlinger Robert |
VP and CIO |
|
2020-07-30 |
4 |
D |
$6.15 |
$3,309 |
D/D |
(538) |
47,769 |
|
- |
|
Israel Samuel H |
Chief Legal Officer |
|
2020-07-30 |
4 |
D |
$6.15 |
$7,042 |
D/D |
(1,145) |
64,852 |
|
- |
|
Abt John |
Chief Quality and Operations |
|
2020-07-30 |
4 |
D |
$6.15 |
$3,026 |
D/D |
(492) |
45,687 |
|
- |
|
Kozlowski John |
VP of Finance & CFO |
|
2020-07-30 |
4 |
D |
$6.15 |
$4,662 |
D/D |
(758) |
47,661 |
|
- |
|
Ehlinger Robert |
VP and CIO |
|
2020-07-29 |
4 |
D |
$6.14 |
$8,915 |
D/D |
(1,452) |
48,307 |
|
- |
|
Israel Samuel H |
Chief Legal Officer |
|
2020-07-29 |
4 |
D |
$6.14 |
$19,359 |
D/D |
(3,153) |
65,997 |
|
- |
|
Abt John |
Chief Quality and Operations |
|
2020-07-29 |
4 |
D |
$6.14 |
$11,040 |
D/D |
(1,798) |
46,179 |
|
- |
|
Kozlowski John |
VP of Finance & CFO |
|
2020-07-29 |
4 |
D |
$6.14 |
$12,526 |
D/D |
(2,040) |
48,419 |
|
- |
|
Cavanaugh Maureen |
Senior Vice President and CCOO |
|
2020-07-29 |
4 |
D |
$6.14 |
$18,678 |
D/D |
(3,042) |
58,547 |
|
- |
|
Israel Samuel H |
Chief Legal Officer |
|
2020-07-15 |
4 |
D |
$5.14 |
$9,812 |
D/D |
(1,909) |
69,150 |
|
- |
|
Landis G. Michael |
Principal Accounting Officer |
|
2020-07-01 |
4 |
D |
$7.07 |
$2,771 |
D/D |
(392) |
37,294 |
|
- |
|
Ehlinger Robert |
VP and CIO |
|
2020-06-30 |
4 |
A |
$5.47 |
$7,778 |
D/D |
1,422 |
49,759 |
|
- |
|
Crew Timothy C |
Chief Executive Officer |
|
2020-06-30 |
4 |
A |
$5.47 |
$8,085 |
D/D |
1,478 |
192,216 |
|
- |
|
Abt John |
Chief Quality and Operations |
|
2020-06-30 |
4 |
A |
$5.47 |
$4,775 |
D/D |
873 |
47,977 |
|
- |
|
Israel Samuel H |
Chief Legal Officer |
|
2020-06-30 |
4 |
A |
$5.47 |
$4,442 |
D/D |
812 |
71,059 |
|
- |
|
Drabik David A |
Director |
|
2020-05-19 |
4 |
S |
$7.37 |
$274,311 |
D/D |
(37,220) |
45,972 |
|
13% |
|
Taveira Paul |
Director |
|
2020-05-19 |
4 |
S |
$7.22 |
$216,600 |
D/D |
(30,000) |
51,415 |
|
13% |
|
Crew Timothy C |
Chief Executive Officer |
|
2020-05-12 |
4 |
AB |
$7.57 |
$22,710 |
D/D |
3,000 |
190,738 |
|
-17% |
|
Cavanaugh Maureen |
Senior Vice President and CCOO |
|
2020-05-07 |
4 |
D |
$7.58 |
$18,071 |
D/D |
(2,384) |
61,589 |
|
- |
|
762 Records found
|
|
Page 5 of 31 |
|
|